Organogenesis Holdings Inc. ORGO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.72M-92.7% | $37.03M+3,585% | $1.01M+112% | -$8.23M+48.2% | -$15.88M-1,945% | ||
| $16M+4.8% | $15.27M+3.0% | $14.82M+3.2% | $14.36M+2.6% | $14M+2.7% | ||
| $13.57M+2.0% | $13.3M+12.1% | $11.87M+3.1% | $11.51M-0.2% | $11.54M+9.1% | ||
| -$4.61M-148% | $9.5M+206% | -$8.96M-22.4% | -$7.32M— | —— | ||
| —— | -$188K+75.6% | -$769K-2.5% | -$750K+7.6% | -$812K+28.8% | ||
| $16.97M-85.3% | $115.8M+58.4% | $73.13M+226% | $22.44M+60.3% | $14M-59.8% | ||
| $18.85M0.0% | $18.85M+15.3% | $16.35M-18.6% | $20.09M— | —— | ||
| -$35K+93.4% | -$528K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $8.19M+146% | $3.32M-1.1% | $3.36M+0.2% | $3.35M+0.2% | $3.34M-1.7% | ||
| $8.83M+5.9% | $8.34M+2.2% | $8.16M+1.3% | $8.06M-1.0% | $8.14M-2.5% | ||
| —— | —— | —— | -$33.18M-848% | $4.44M-68.8% | ||
| $13.67M-3.4% | $14.15M+10.0% | $12.86M-2.5% | $13.19M+15.4% | $11.44M+14.0% | ||
| -$13.67M+3.4% | -$14.15M-10.0% | -$12.86M+2.5% | -$13.19M-15.4% | -$11.44M-14.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | $157K-87.1% | $1.22M+11.5% | $1.09M0.0% | $1.09M-12.4% | ||
| $10.73M+816% | $1.17M+2.2% | $1.15M+1.8% | $1.13M+2.0% | $1.1M+2.1% | ||
| $3.14M+66.6% | $1.89M+4.7% | $1.8M+0.1% | $1.8M-2.9% | $1.85M+57.5% | ||
| —— | —— | —— | —— | —— | ||
| -$35.52M-105% | -$17.36M-182% | $21.1M-28.8% | $29.63M+5.1% | $28.19M+2.0% | ||
| —— | —— | -$30.55M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $5.35M-3.8% | $5.56M-6.7% | $5.96M-15.8% | $7.08M+1.7% | ||
| -$18.63M-21.4% | -$15.35M-49.2% | -$10.29M-4.6% | -$9.83M-4.6% | -$9.4M-14.5% | ||
| $8.19M+146% | $3.32M-1.1% | $3.36M+0.2% | $3.35M+0.2% | $3.34M-1.7% | ||
| —— | —— | —— | —— | —— | ||
| -$1.11M-111% | $10.38M+675% | $1.34M— | —— | —— | ||
| $8.85M+4.3% | $8.49M-23.6% | $11.12M-9.7% | $12.31M-11.5% | $13.9M-1.2% | ||
| —— | —— | —— | —— | —— | ||
| $397K+5.9% | $375K+29.8% | $289K-10.8% | $324K-9.5% | $358K-9.1% | ||
| $8.83M+5.9% | $8.34M+2.2% | $8.16M+1.3% | $8.06M-1.0% | $8.14M-2.5% | ||
| $3.38M-58.8% | $8.21M+46.2% | $5.62M+11.9% | $5.02M+30.7% | $3.84M-2.4% | ||
| —— | $11.18M— | —— | —— | —— | ||
| $18.17M+25.6% | $14.46M— | —— | —— | —— | ||
| $10.73M+816% | $1.17M+2.2% | $1.15M+1.8% | $1.13M+2.0% | $1.1M+2.1% | ||
| —— | —— | —— | —— | —— | ||
| $11.63M+2.2% | $11.37M+28.0% | $8.88M+37.5% | $6.46M+57.6% | $4.1M+128% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $2.69M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $26.98M+329% | $6.3M+3.1% | $6.11M+0.9% | $6.05M+18.4% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Organogenesis Holdings Inc. generate?
- Organogenesis Holdings Inc. (ORGO) generated -$20.7M in operating cash flow over the trailing twelve months.
- What is Organogenesis Holdings Inc.'s free cash flow?
- After $13.7M of capital expenditures, Organogenesis Holdings Inc.'s free cash flow was -$34.5M over the trailing twelve months, down 67.6% year over year.
- Where does Organogenesis Holdings Inc.'s cash flow data come from?
- Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
